TECSUN PHARMA LIMITED, a leading pharmaceutical company founded in 2005, has announced a breakthrough in the treatment of respiratory infections. The company, which specializes in the development, pro

TECSUN PHARMA LIMITED, a joint-stock company founded in 2005, has announced a significant development in its pharmaceutical products. The company's business scope includes the development, production,

TECSUN PHARMA LIMITED, a leading pharmaceutical company, has made significant strides in the development of a new drug, which has shown promising results in the treatment of a debilitating parasitic i

TECSUN PHARMA LIMITED, a leading pharmaceutical company founded in 2005, has announced a breakthrough in the development of Vitamin B3 that is set to revolutionize the industry. The company, with its

TECSUN PHARMA LIMITED, a joint-stock company founded in 2005, has announced the launch of Tilmicosin Phosphate 25% Premix, a macrolides antibiotic special for animals that is resistant to G+, mycoplas

WHL playoffs: ICE Triumph over Warriors in a Stunning Win In an exciting twist, The Winnipeg ICE have taken home the win against the Moose Jaw Warriors in a 5-2 victory in the Western Hockey League p

piece on the significance of diclofenac sodium as a pharmaceutical raw material. Diclofenac sodium, also known as Voltaren, is a non-steroidal anti-inflammatory drug (NSAID) that has been used for ov

TECSUN PHARMA LIMITED, a leading joint-stock pharmaceutical company, has recently introduced a new generic drug, Renerve Plus Capsule (1500mcg/200mg/1.5mg/100mg/200mcg/55mcg/25mg) to the Indian market

article as a science reporter covering the recent developments and potential applications of Cefradine in the pharmaceutical industry, incorporating interviews with industry experts and medical profes

TECSUN PHARMA LIMITED, a joint-stock company founded in 2005, has established itself as a leading manufacturer and supplier of Ferrous sulfate Monohyddrate Powder | FeH2O5S in Oman. The company has be